CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860103. A total of 41 filers reported holding CLEVELAND BIOLABS INC in Q4 2013. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $0 | – | 203,078 | 0.0% | 0.00% | – |
Q3 2014 | $0 | – | 203,078 | 0.0% | 0.00% | – |
Q2 2014 | $0 | -100.0% | 203,078 | 0.0% | 0.00% | – |
Q1 2014 | $1,000 | -95.2% | 203,078 | 0.0% | 0.00% | -100.0% |
Q4 2013 | $21,000 | +2000.0% | 203,078 | 0.0% | 0.00% | – |
Q3 2013 | $1,000 | -75.0% | 203,078 | 0.0% | 0.00% | – |
Q2 2013 | $4,000 | – | 203,078 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 1,826,158 | $1,244,000 | 0.07% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 721,200 | $507,000 | 0.02% |
Winfield Associates, Inc. | 15,711 | $11,000 | 0.01% |
Van Cleef Asset Management,Inc | 20,000 | $14,000 | 0.01% |
ACG Wealth | 25,000 | $17,000 | 0.01% |
TAURUS ASSET MANAGEMENT, LLC | 15,000 | $10,000 | 0.00% |
OPPENHEIMER & CO INC | 25,500 | $17,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 3,000 | $2,000 | 0.00% |
NORTHERN TRUST CORP | 72,158 | $49,000 | 0.00% |
AMERIPRISE FINANCIAL INC | 50 | $0 | 0.00% |